Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of AZD0543 in Healthy Adults
NCT07824622Phase 1Recruiting
- Sponsor
- AstraZeneca
- Start
- Aug 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1 trial of AZD0543 in human metapneumovirus infection (HMPV), sponsored by AstraZeneca. Started Aug 2026; status: recruiting.
02
Drugs
AZD0543
03
Conditions
human metapneumovirus infection (HMPV)
Beyond the preview
Go deeper on NCT07824622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824622.